메뉴 건너뛰기




Volumn 10, Issue 2, 2014, Pages 255-272

Targeting mitochondria for cardioprotection: Examining the benefit for patients

Author keywords

Cardioprotection; heart failure; ischemic conditioning; left ventricular failure; mitochondrial dysfunction; mitochondrial metabolism; mitochondrial permeability transition pore; myocardial ischemia reperfusion injury

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ALISPORIVIR; CALCINEURIN; CARDIOVASCULAR AGENT; CARNITINE; CREATINE KINASE MB; CYCLOSPORIN A; CYCLOSPORIN A [4 N METHYLISOLEUCINE]; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; G PROTEIN COUPLED RECEPTOR; IDEBENONE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; NITRIC OXIDE; ORGANIC NITRATE; PEPTIDE; RIBOFLAVIN; SANGLIFEHRIN A; SZETO SCHILLER PEPTIDE; TRO 40303; TROPONIN I; UBIDECARENONE; UNCLASSIFIED DRUG; (MELLE-4)CYCLOSPORIN; 3,5-SECO-4-NORCHOLESTAN-5-ONE OXIME-3-OL; CARDIOTONIC AGENT; CARRIER PROTEIN; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MITOQUINONE; ORGANOPHOSPHORUS COMPOUND; OXIME; REACTIVE OXYGEN METABOLITE; SCAVENGER; SECOSTEROID; UBIQUINONE;

EID: 84899512329     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/fca.14.6     Document Type: Review
Times cited : (34)

References (116)
  • 1
    • 84864598311 scopus 로고    scopus 로고
    • Long-term survival and recurrence after acute myocardial infarction in England 2004 to 2010
    • Smolina K, Wright FL, Rayner M et al. Long-term survival and recurrence after acute myocardial infarction in England, 2004 to 2010. Circ. Cardiovasc. Qual. Outcomes 5(4), 532-540 (2012).
    • (2012) Circ. Cardiovasc. Qual. Outcomes , vol.5 , Issue.4 , pp. 532-540
    • Smolina, K.1    Wright, F.L.2    Rayner, M.3
  • 2
    • 84867362492 scopus 로고    scopus 로고
    • Third universal definition of myocardial infarction
    • Thygesen K, Alpert JS, Jaffe AS et al. Third universal definition of myocardial infarction. J. Am. Coll. Cardiol. 60(16), 1581-1598 (2012).
    • (2012) J. Am. Coll. Cardiol. , vol.60 , Issue.16 , pp. 1581-1598
    • Thygesen, K.1    Alpert, J.S.2    Jaffe, A.S.3
  • 3
    • 84875170063 scopus 로고    scopus 로고
    • Translating cardioprotection for patient benefit: Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology
    • Hausenloy DJ, Erik BH, Condorelli G et al. Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc. Res. 98(1), 7-27 (2013).
    • (2013) Cardiovasc. Res. , vol.98 , Issue.1 , pp. 7-27
    • Hausenloy, D.J.1    Erik, B.H.2    Condorelli, G.3
  • 5
    • 84891706291 scopus 로고    scopus 로고
    • Mechanisms of disease: Is mitochondrial function altered in heart failure
    • Hamilton DJ. Mechanisms of disease: is mitochondrial function altered in heart failure Methodist Debakey Cardiovasc J. 9(1), 44-48 (2013).
    • (2013) Methodist Debakey Cardiovasc J. , vol.9 , Issue.1 , pp. 44-48
    • Hamilton, D.J.1
  • 6
    • 84867691699 scopus 로고    scopus 로고
    • Mitochondrial control of cellular life, stress, and death
    • Galluzzi L, Kepp O, Trojel-Hansen C et al. Mitochondrial control of cellular life, stress, and death. Circ. Res. 111(9), 1198-1207 (2012).
    • (2012) Circ. Res. , vol.111 , Issue.9 , pp. 1198-1207
    • Galluzzi, L.1    Kepp, O.2    Trojel-Hansen, C.3
  • 7
    • 84875068490 scopus 로고    scopus 로고
    • Targeting mitochondrial oxidative metabolism as an approach to treat heart failure
    • Fillmore N, Lopaschuk GD. Targeting mitochondrial oxidative metabolism as an approach to treat heart failure. Biochim. Biophys. Acta 1833(4), 857-865 (2013).
    • (2013) Biochim. Biophys. Acta , vol.1833 , Issue.4 , pp. 857-865
    • Fillmore, N.1    Lopaschuk, G.D.2
  • 9
    • 84862908305 scopus 로고    scopus 로고
    • Cardiomyocyte death: Mechanisms and translational implications
    • Chiong M, Wang ZV, Pedrozo Z et al. Cardiomyocyte death: mechanisms and translational implications. Cell Death Dis. 2, e244 (2011).
    • (2011) Cell Death Dis. , vol.2
    • Chiong, M.1    Wang, Z.V.2    Pedrozo, Z.3
  • 10
    • 84873848690 scopus 로고    scopus 로고
    • Myocardial ischemia-reperfusion injury: A neglected therapeutic target
    • Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J. Clin. Invest. 123(1), 92-100 (2013).
    • (2013) J. Clin. Invest. , vol.123 , Issue.1 , pp. 92-100
    • Hausenloy, D.J.1    Yellon, D.M.2
  • 11
    • 80051506119 scopus 로고    scopus 로고
    • Cell death pathways in acute ischemia/reperfusion injury
    • Gottlieb RA. Cell death pathways in acute ischemia/reperfusion injury. J. Cardiovasc. Pharmacol. Ther. 16(3-4), 233-238 (2011).
    • (2011) J. Cardiovasc. Pharmacol. Ther. , vol.16 , Issue.3-4 , pp. 233-238
    • Gottlieb, R.A.1
  • 12
    • 62249162170 scopus 로고    scopus 로고
    • The mitochondrial permeability transition pore and ischemia-reperfusion injury
    • Baines CP. The mitochondrial permeability transition pore and ischemia-reperfusion injury. Basic Res. Cardiol. 104(2), 181-188 (2009).
    • (2009) Basic Res. Cardiol. , vol.104 , Issue.2 , pp. 181-188
    • Baines, C.P.1
  • 13
    • 67349164763 scopus 로고    scopus 로고
    • A CaPful of mechanisms regulating the mitochondrial permeability transition
    • Di Lisa F, Bernardi P. A CaPful of mechanisms regulating the mitochondrial permeability transition. J. Mol. Cell. Cardiol. 46(6), 775-780 (2009).
    • (2009) J. Mol. Cell. Cardiol. , vol.46 , Issue.6 , pp. 775-780
    • Di Lisa, F.1    Bernardi, P.2
  • 14
    • 84870278725 scopus 로고    scopus 로고
    • Mitochondrial membrane permeabilization and cell death during myocardial infarction: Roles of calcium and reactive oxygen species
    • Webster KA. Mitochondrial membrane permeabilization and cell death during myocardial infarction: roles of calcium and reactive oxygen species. Future Cardiol. 8(6), 863-884 (2012).
    • (2012) Future Cardiol. , vol.8 , Issue.6 , pp. 863-884
    • Webster, K.A.1
  • 15
    • 84877011174 scopus 로고    scopus 로고
    • Targeting cell death in the reperfused heart: Pharmacological approaches for cardioprotection
    • Oerlemans MI, Koudstaal S, Chamuleau SA et al. Targeting cell death in the reperfused heart: pharmacological approaches for cardioprotection. Int. J. Cardiol. 165(3), 410-422 (2013).
    • (2013) Int. J. Cardiol. , vol.165 , Issue.3 , pp. 410-422
    • Oerlemans, M.I.1    Koudstaal, S.2    Chamuleau, S.A.3
  • 16
    • 33644840693 scopus 로고    scopus 로고
    • Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
    • Degterev A, Huang Z, Boyce M et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat. Chem. Biol. 1(2), 112-119 (2005).
    • (2005) Nat. Chem. Biol. , vol.1 , Issue.2 , pp. 112-119
    • Degterev, A.1    Huang, Z.2    Boyce, M.3
  • 17
    • 80052173847 scopus 로고    scopus 로고
    • Necroptosis, necrostatins and tissue injury
    • Smith CC, Yellon DM. Necroptosis, necrostatins and tissue injury. J. Cell. Mol. Med. 15(9), 1797-1806 (2011).
    • (2011) J. Cell. Mol. Med. , vol.15 , Issue.9 , pp. 1797-1806
    • Smith, C.C.1    Yellon, D.M.2
  • 18
    • 62249102192 scopus 로고    scopus 로고
    • The mitochondrial permeability transition pore as a target for preconditioning and postconditioning
    • Hausenloy DJ, Ong SB, Yellon DM. The mitochondrial permeability transition pore as a target for preconditioning and postconditioning. Basic Res. Cardiol. 104(2), 189-202 (2009).
    • (2009) Basic Res. Cardiol. , vol.104 , Issue.2 , pp. 189-202
    • Hausenloy, D.J.1    Ong, S.B.2    Yellon, D.M.3
  • 19
    • 84881342113 scopus 로고    scopus 로고
    • Cardioprotection techniques: Preconditioning, postconditioning and remote conditioning (basic science)
    • Hausenloy DJ. Cardioprotection techniques: preconditioning, postconditioning and remote conditioning (basic science). Curr. Pharm. Des. 19(25), 4544-4563 (2013).
    • (2013) Curr. Pharm. Des. , vol.19 , Issue.25 , pp. 4544-4563
    • Hausenloy, D.J.1
  • 20
    • 34548044947 scopus 로고    scopus 로고
    • Preconditioning and postconditioning: United at reperfusion
    • Hausenloy DJ, Yellon DM. Preconditioning and postconditioning: united at reperfusion. Pharmacol. Ther. 116(2), 173-191 (2007).
    • (2007) Pharmacol. Ther. , vol.116 , Issue.2 , pp. 173-191
    • Hausenloy, D.J.1    Yellon, D.M.2
  • 21
    • 46849092968 scopus 로고    scopus 로고
    • Nitrate-induced toxicity and preconditioning: A rationale for reconsidering the use of these drugs
    • Gori T, Parker JD. Nitrate-induced toxicity and preconditioning: a rationale for reconsidering the use of these drugs. J. Am. Coll. Cardiol. 52(4), 251-254 (2008).
    • (2008) J. Am. Coll. Cardiol. , vol.52 , Issue.4 , pp. 251-254
    • Gori, T.1    Parker, J.D.2
  • 22
    • 0022970945 scopus 로고
    • Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium
    • Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74(5), 1124-1136 (1986).
    • (1986) Circulation , vol.74 , Issue.5 , pp. 1124-1136
    • Murry, C.E.1    Jennings, R.B.2    Reimer, K.A.3
  • 23
    • 0141751749 scopus 로고    scopus 로고
    • Preconditioning the myocardium: From cellular physiology to clinical cardiology
    • Yellon DM, Downey JM. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol. Rev. 83(4), 1113-1151 (2003).
    • (2003) Physiol. Rev. , vol.83 , Issue.4 , pp. 1113-1151
    • Yellon, D.M.1    Downey, J.M.2
  • 24
    • 80051509872 scopus 로고    scopus 로고
    • Commentary on selected aspects of cardioprotection
    • Jennings RB. Commentary on selected aspects of cardioprotection. J. Cardiovasc. Pharmacol. Ther. 16(3-4), 340-348 (2011).
    • (2011) J. Cardiovasc. Pharmacol. Ther. , vol.16 , Issue.3-4 , pp. 340-348
    • Jennings, R.B.1
  • 25
    • 0031002408 scopus 로고    scopus 로고
    • Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery
    • Jenkins DP, Pugsley WB, Alkhulaifi AM et al. Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. Heart 77(4), 314-318 (1997).
    • (1997) Heart , vol.77 , Issue.4 , pp. 314-318
    • Jenkins, D.P.1    Pugsley, W.B.2    Alkhulaifi, A.M.3
  • 26
    • 0027301398 scopus 로고
    • Preconditioning the human myocardium
    • Yellon DM, Alkhulaifi AM, Pugsley WB. Preconditioning the human myocardium. Lancet 342(8866), 276-277 (1993).
    • (1993) Lancet , vol.342 , Issue.8866 , pp. 276-277
    • Yellon, D.M.1    Alkhulaifi, A.M.2    Pugsley, W.B.3
  • 27
    • 38349054173 scopus 로고    scopus 로고
    • Effect of ischemic postconditioning in adult valve replacement
    • Luo W, Li B, Chen R et al. Effect of ischemic postconditioning in adult valve replacement. Eur. J. Cardiothorac. Surg. 33(2), 203-208 (2008).
    • (2008) Eur. J. Cardiothorac. Surg. , vol.33 , Issue.2 , pp. 203-208
    • Luo, W.1    Li, B.2    Chen, R.3
  • 28
    • 84864721500 scopus 로고    scopus 로고
    • The efficacies of modified mechanical post conditioning on myocardial protection for patients undergoing coronary artery bypass grafting
    • Durdu S, Sirlak M, Cetintas D et al. The efficacies of modified mechanical post conditioning on myocardial protection for patients undergoing coronary artery bypass grafting. J. Cardiothorac. Surg. 7, 73 (2012).
    • (2012) J. Cardiothorac. Surg. , vol.7 , Issue.73
    • Durdu, S.1    Sirlak, M.2    Cetintas, D.3
  • 29
    • 34848831837 scopus 로고    scopus 로고
    • Reduction in myocardial infarct size by postconditioning in patients after percutaneous coronary intervention
    • Yang XC, Liu Y, Wang LF et al. Reduction in myocardial infarct size by postconditioning in patients after percutaneous coronary intervention. J. Invasive Cardiol. 19(10), 424-430 (2007).
    • (2007) J. Invasive Cardiol. , vol.19 , Issue.10 , pp. 424-430
    • Yang, X.C.1    Liu, Y.2    Wang, L.F.3
  • 30
    • 40749130846 scopus 로고    scopus 로고
    • Long-term benefit of postconditioning
    • Thibault H, Piot C, Staat P et al. Long-term benefit of postconditioning. Circulation 117(8), 1037-1044 (2008).
    • (2008) Circulation , vol.117 , Issue.8 , pp. 1037-1044
    • Thibault, H.1    Piot, C.2    Staat, P.3
  • 31
    • 84862983669 scopus 로고    scopus 로고
    • Effect of postconditioning in patients with ST-elevation acute myocardial infarction
    • Ugata Y, Nakamura T, Taniguchi Y et al. Effect of postconditioning in patients with ST-elevation acute myocardial infarction. Cardiovasc. Interv. Ther. 27(1), 14-18 (2012).
    • (2012) Cardiovasc. Interv. Ther. , vol.27 , Issue.1 , pp. 14-18
    • Ugata, Y.1    Nakamura, T.2    Taniguchi, Y.3
  • 32
    • 78049281398 scopus 로고    scopus 로고
    • Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction
    • Sorensson P, Saleh N, Bouvier F et al. Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction. Heart 96(21), 1710-1715 (2010).
    • (2010) Heart , vol.96 , Issue.21 , pp. 1710-1715
    • Sorensson, P.1    Saleh, N.2    Bouvier, F.3
  • 33
    • 84875310813 scopus 로고    scopus 로고
    • Long-term impact of postconditioning on infarct size and left ventricular ejection fraction in patients with ST-elevation myocardial infarction
    • Sorensson P, Ryden L, Saleh N et al. Long-term impact of postconditioning on infarct size and left ventricular ejection fraction in patients with ST-elevation myocardial infarction. BMC Cardiovasc. Disord. 13, 22 (2013).
    • (2013) BMC Cardiovasc. Disord. , vol.13 , Issue.22
    • Sorensson, P.1    Ryden, L.2    Saleh, N.3
  • 34
    • 84870241753 scopus 로고    scopus 로고
    • Postconditioning during coronary angioplasty in acute myocardial infarction: The POST-AMI trial
    • Tarantini G, Favaretto E, Marra MP et al. Postconditioning during coronary angioplasty in acute myocardial infarction: the POST-AMI trial. Int. J. Cardiol. 162(1), 33-38 (2012).
    • (2012) Int. J. Cardiol. , vol.162 , Issue.1 , pp. 33-38
    • Tarantini, G.1    Favaretto, E.2    Marra, M.P.3
  • 35
    • 84855512864 scopus 로고    scopus 로고
    • Ischaemic postconditioning revisited: Lack of effects on infarct size following primary percutaneous coronary intervention
    • Freixa X, Bellera N, Ortiz-Perez JT et al. Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention. Eur. Heart J. 33(1), 103-112 (2012).
    • (2012) Eur. Heart J. , vol.33 , Issue.1 , pp. 103-112
    • Freixa, X.1    Bellera, N.2    Ortiz-Perez, J.T.3
  • 36
    • 33646932408 scopus 로고    scopus 로고
    • Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: First clinical application in humans
    • Cheung MM, Kharbanda RK, Konstantinov IE et al. Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. J. Am. Coll. Cardiol. 47(11), 2277-2282 (2006).
    • (2006) J. Am. Coll. Cardiol. , vol.47 , Issue.11 , pp. 2277-2282
    • Cheung, M.M.1    Kharbanda, R.K.2    Konstantinov, I.E.3
  • 37
    • 34547837402 scopus 로고    scopus 로고
    • Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: A randomised controlled trial
    • Hausenloy DJ, Mwamure PK, Venugopal V et al. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet 370(9587), 575-579 (2007).
    • (2007) Lancet , vol.370 , Issue.9587 , pp. 575-579
    • Hausenloy, D.J.1    Mwamure, P.K.2    Venugopal, V.3
  • 38
    • 70349446441 scopus 로고    scopus 로고
    • Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold-blood cardioplegia: A randomised controlled trial
    • Venugopal V, Hausenloy DJ, Ludman A et al. Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold-blood cardioplegia: a randomised controlled trial. Heart 95(19), 1567-1571 (2009).
    • (2009) Heart , vol.95 , Issue.19 , pp. 1567-1571
    • Venugopal, V.1    Hausenloy, D.J.2    Ludman, A.3
  • 39
    • 77955866454 scopus 로고    scopus 로고
    • Induced remote ischemic pre-conditioning on ischemia-reperfusion injury in patients undergoing coronary artery bypass
    • Ali N, Rizwi F, Iqbal A et al. Induced remote ischemic pre-conditioning on ischemia-reperfusion injury in patients undergoing coronary artery bypass. J. Coll. Physicians Surg. Pak. 20(7), 427-431 (2010).
    • (2010) J. Coll. Physicians Surg. Pak. , vol.20 , Issue.7 , pp. 427-431
    • Ali, N.1    Rizwi, F.2    Iqbal, A.3
  • 40
    • 84882265326 scopus 로고    scopus 로고
    • Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: A single-centre randomised, double-blind, controlled trial
    • Thielmann M, Kottenberg E, Kleinbongard P et al. Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial. Lancet 382(9892), 597-604 (2013).
    • (2013) Lancet , vol.382 , Issue.9892 , pp. 597-604
    • Thielmann, M.1    Kottenberg, E.2    Kleinbongard, P.3
  • 41
    • 74049108136 scopus 로고    scopus 로고
    • Cardioprotective role of remote ischemic periconditioning in primary percutaneous coronary intervention: Enhancement by opioid action
    • Rentoukas I, Giannopoulos G, Kaoukis A et al. Cardioprotective role of remote ischemic periconditioning in primary percutaneous coronary intervention: enhancement by opioid action. JACC Cardiovasc. Interv. 3(1), 49-55 (2010).
    • (2010) JACC Cardiovasc. Interv. , vol.3 , Issue.1 , pp. 49-55
    • Rentoukas, I.1    Giannopoulos, G.2    Kaoukis, A.3
  • 42
    • 77249107745 scopus 로고    scopus 로고
    • Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: A randomised trial
    • Botker HE, Kharbanda R, Schmidt MR et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 375(9716), 727-734 (2010).
    • (2010) Lancet , vol.375 , Issue.9716 , pp. 727-734
    • Botker, H.E.1    Kharbanda, R.2    Schmidt, M.R.3
  • 43
    • 78650285662 scopus 로고    scopus 로고
    • Remote ischemic conditioning in patients with myocardial infarction treated with primary angioplasty: Impact on left ventricular function assessed by comprehensive echocardiography and gated single-photon emission CT
    • Munk K, Andersen NH, Schmidt MR et al. Remote ischemic conditioning in patients with myocardial infarction treated with primary angioplasty: impact on left ventricular function assessed by comprehensive echocardiography and gated single-photon emission CT. Circ. Cardiovasc. Imaging 3(6), 656-662 (2010).
    • (2010) Circ. Cardiovasc. Imaging , vol.3 , Issue.6 , pp. 656-662
    • Munk, K.1    Andersen, N.H.2    Schmidt, M.R.3
  • 44
    • 4043060632 scopus 로고    scopus 로고
    • Postconditioning: A form of modified reperfusion protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway
    • Tsang A, Hausenloy DJ, Mocanu MM et al. Postconditioning: a form of modified reperfusion protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ. Res. 95(3), 230-232 (2004).
    • (2004) Circ. Res. , vol.95 , Issue.3 , pp. 230-232
    • Tsang, A.1    Hausenloy, D.J.2    Mocanu, M.M.3
  • 45
    • 12344317925 scopus 로고    scopus 로고
    • Postconditioning inhibits mitochondrial permeability transition
    • Argaud L, Gateau-Roesch O, Raisky O et al. Postconditioning inhibits mitochondrial permeability transition. Circulation 111(2), 194-197 (2005).
    • (2005) Circulation , vol.111 , Issue.2 , pp. 194-197
    • Argaud, L.1    Gateau-Roesch, O.2    Raisky, O.3
  • 46
    • 34447507839 scopus 로고    scopus 로고
    • Preconditioning and postconditioning: The essential role of the mitochondrial permeability transition pore
    • Lim SY, Davidson SM, Hausenloy DJ et al. Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore. Cardiovasc. Res. 75(3), 530-535 (2007).
    • (2007) Cardiovasc. Res. , vol.75 , Issue.3 , pp. 530-535
    • Lim, S.Y.1    Davidson, S.M.2    Hausenloy, D.J.3
  • 47
    • 33645736864 scopus 로고    scopus 로고
    • Ischemic postconditioning during reperfusion activates Akt and ERK without protecting against lethal myocardial ischemia-reperfusion injury in pigs
    • Schwartz LM, Lagranha CJ. Ischemic postconditioning during reperfusion activates Akt and ERK without protecting against lethal myocardial ischemia-reperfusion injury in pigs. Am. J. Physiol. Heart Circ. Physiol. 290(3), H1011-H1018 (2006).
    • (2006) Am. J. Physiol. Heart Circ. Physiol. , vol.290 , Issue.3
    • Schwartz, L.M.1    Lagranha, C.J.2
  • 48
    • 34249693654 scopus 로고    scopus 로고
    • Postconditioning does not reduce myocardial infarct size in an in vivo regional ischemia rodent model
    • Dow J, Kloner RA. Postconditioning does not reduce myocardial infarct size in an in vivo regional ischemia rodent model. J. Cardiovasc. Pharmacol. Ther. 12(2), 153-163 (2007).
    • (2007) J. Cardiovasc. Pharmacol. Ther. , vol.12 , Issue.2 , pp. 153-163
    • Dow, J.1    Kloner, R.A.2
  • 49
    • 38149068092 scopus 로고    scopus 로고
    • Postconditioning fails to improve no reflow or alter infarct size in an open-chest rabbit model of myocardial ischemia-reperfusion
    • Hale SL, Mehra A, Leeka J et al. Postconditioning fails to improve no reflow or alter infarct size in an open-chest rabbit model of myocardial ischemia-reperfusion. Am. J. Physiol. Heart Circ. Physiol. 294(1), H421-H425 (2008).
    • (2008) Am. J. Physiol. Heart Circ. Physiol. , vol.294 , Issue.1
    • Hale, S.L.1    Mehra, A.2    Leeka, J.3
  • 50
    • 77953682356 scopus 로고    scopus 로고
    • Cardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance
    • Lonborg J, Kelbaek H, Vejlstrup N et al. Cardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance. Circ. Cardiovasc. Interv. 3(1), 34-41 (2010).
    • (2010) Circ. Cardiovasc. Interv. , vol.3 , Issue.1 , pp. 34-41
    • Lonborg, J.1    Kelbaek, H.2    Vejlstrup, N.3
  • 51
    • 77957863131 scopus 로고    scopus 로고
    • Postconditioning during primary percutaneous coronary intervention: A review and meta-analysis
    • Hansen PR, Thibault H, Abdulla J. Postconditioning during primary percutaneous coronary intervention: a review and meta-analysis. Int. J. Cardiol. 144(1), 22-25 (2010).
    • (2010) Int. J. Cardiol. , vol.144 , Issue.1 , pp. 22-25
    • Hansen, P.R.1    Thibault, H.2    Abdulla, J.3
  • 52
    • 84855474703 scopus 로고    scopus 로고
    • Reduction of infarct size by ischaemic post-conditioning in humans: Fact or fiction Eur
    • Heusch G. Reduction of infarct size by ischaemic post-conditioning in humans: fact or fiction Eur. Heart J. 33(1), 13-15 (2012).
    • (2012) Heart J. , vol.33 , Issue.1 , pp. 13-15
    • Heusch, G.1
  • 53
    • 80755125546 scopus 로고    scopus 로고
    • Myocardial postconditioning: Next step to cardioprotection
    • Rohilla A, Rohilla S, Kushnoor A. Myocardial postconditioning: next step to cardioprotection. Arch. Pharm. Res. 34(9), 1409-1415 (2011).
    • (2011) Arch. Pharm. Res. , vol.34 , Issue.9 , pp. 1409-1415
    • Rohilla, A.1    Rohilla, S.2    Kushnoor, A.3
  • 54
    • 84870293744 scopus 로고    scopus 로고
    • Local ischemic postconditioning during primary percutaneous coronary intervention: A meta-analysis
    • Wei Y, Ruan L, Zhou G et al. Local ischemic postconditioning during primary percutaneous coronary intervention: a meta-analysis. Cardiology 123(4), 225-233 (2012).
    • (2012) Cardiology , vol.123 , Issue.4 , pp. 225-233
    • Wei, Y.1    Ruan, L.2    Zhou, G.3
  • 55
    • 0027401466 scopus 로고
    • Regional ischemic preconditioning protects remote virgin myocardium from subsequent sustained coronary occlusion
    • Przyklenk K, Bauer B, Ovize M et al. Regional ischemic preconditioning protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 87(3), 893-899 (1993).
    • (1993) Circulation , vol.87 , Issue.3 , pp. 893-899
    • Przyklenk, K.1    Bauer, B.2    Ovize, M.3
  • 56
    • 0037016064 scopus 로고    scopus 로고
    • Transient limb ischemia induces remote ischemic preconditioning in vivo
    • Kharbanda RK, Mortensen UM, White PA et al. Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation 106(23), 2881-2883 (2002).
    • (2002) Circulation , vol.106 , Issue.23 , pp. 2881-2883
    • Kharbanda, R.K.1    Mortensen, U.M.2    White, P.A.3
  • 57
    • 34147172678 scopus 로고    scopus 로고
    • Intermittent peripheral tissue ischemia during coronary ischemia reduces myocardial infarction through a KATP-dependent mechanism: First demonstration of remote ischemic preconditioning
    • Schmidt MR, Smerup M, Konstantinov IE et al. Intermittent peripheral tissue ischemia during coronary ischemia reduces myocardial infarction through a KATP-dependent mechanism: first demonstration of remote ischemic perconditioning. Am. J. Physiol. Heart Circ. Physiol. 292(4), H1883-H1890 (2007).
    • (2007) Am. J. Physiol. Heart Circ. Physiol. , vol.292 , Issue.4
    • Schmidt, M.R.1    Smerup, M.2    Konstantinov, I.E.3
  • 58
    • 34249277833 scopus 로고    scopus 로고
    • Remote ischaemic postconditioning protects the heart during acute myocardial infarction in pigs
    • Andreka G, Vertesaljai M, Szantho G et al. Remote ischaemic postconditioning protects the heart during acute myocardial infarction in pigs. Heart 93(6), 749-752 (2007).
    • (2007) Heart , vol.93 , Issue.6 , pp. 749-752
    • Andreka, G.1    Vertesaljai, M.2    Szantho, G.3
  • 59
    • 84860837867 scopus 로고    scopus 로고
    • Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): Rationale and study design of a multi-centre randomized double-blinded controlled clinical trial
    • Hausenloy DJ, Candilio L, Laing C et al. Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multi-centre randomized double-blinded controlled clinical trial. Clin. Res. Cardiol. 101(5), 339-348 (2012).
    • (2012) Clin. Res. Cardiol. , vol.101 , Issue.5 , pp. 339-348
    • Hausenloy, D.J.1    Candilio, L.2    Laing, C.3
  • 60
    • 84863601363 scopus 로고    scopus 로고
    • Remote ischaemic preconditioning for heart surgery. The study design for a multi-center randomized double-blinded controlled clinical trial-The RIPHeart-Study
    • Meybohm P, Zacharowski K, Cremer J et al. Remote ischaemic preconditioning for heart surgery. The study design for a multi-center randomized double-blinded controlled clinical trial-The RIPHeart-Study. Eur. Heart J. 33(12), 1423-1426 (2012).
    • (2012) Eur. Heart J. , vol.33 , Issue.12 , pp. 1423-1426
    • Meybohm, P.1    Zacharowski, K.2    Cremer, J.3
  • 62
    • 84857098116 scopus 로고    scopus 로고
    • Cyclosporin A and cardioprotection: From investigative tool to therapeutic agent
    • Hausenloy DJ, Boston-Griffiths EA, Yellon DM. Cyclosporin A and cardioprotection: from investigative tool to therapeutic agent. Br. J. Pharmacol. 165(5), 1235-1245 (2012).
    • (2012) Br. J. Pharmacol. , vol.165 , Issue.5 , pp. 1235-1245
    • Hausenloy, D.J.1    Boston-Griffiths, E.A.2    Yellon, D.M.3
  • 63
    • 0036023641 scopus 로고    scopus 로고
    • Inhibiting mitochondrial permeability transition pore opening: A new paradigm for myocardial preconditioning
    • Hausenloy DJ, Maddock HL, Baxter GF et al. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning Cardiovasc. Res. 55(3), 534-543 (2002).
    • (2002) Cardiovasc. Res. , vol.55 , Issue.3 , pp. 534-543
    • Hausenloy, D.J.1    Maddock, H.L.2    Baxter, G.F.3
  • 64
    • 77951294419 scopus 로고    scopus 로고
    • Cyclosporine A at reperfusion reduces infarct size in pigs
    • Skyschally A, Schulz R, Heusch G. Cyclosporine A at reperfusion reduces infarct size in pigs. Cardiovasc. Drugs Ther. 24(1), 85-87 (2010).
    • (2010) Cardiovasc. Drugs Ther. , vol.24 , Issue.1 , pp. 85-87
    • Skyschally, A.1    Schulz, R.2    Heusch, G.3
  • 65
    • 13444282326 scopus 로고    scopus 로고
    • Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury
    • Argaud L, Gateau-Roesch O, Muntean D et al. Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury. J. Mol. Cell. Cardiol. 38(2), 367-374 (2005).
    • (2005) J. Mol. Cell. Cardiol. , vol.38 , Issue.2 , pp. 367-374
    • Argaud, L.1    Gateau-Roesch, O.2    Muntean, D.3
  • 66
    • 77951912363 scopus 로고    scopus 로고
    • Cyclosporine does not reduce myocardial infarct size in a porcine ischemia-reperfusion model
    • Karlsson LO, Zhou AX, Larsson E et al. Cyclosporine does not reduce myocardial infarct size in a porcine ischemia-reperfusion model. J. Cardiovasc. Pharmacol. Ther. 15(2), 182-189 (2010).
    • (2010) J. Cardiovasc. Pharmacol. Ther. , vol.15 , Issue.2 , pp. 182-189
    • Karlsson, L.O.1    Zhou, A.X.2    Larsson, E.3
  • 67
    • 78649751904 scopus 로고    scopus 로고
    • Cyclosporine A administered during reperfusion fails to restore cardioprotection in prediabetic Zucker obese rats in vivo
    • Huhn R, Heinen A, Hollmann MW et al. Cyclosporine A administered during reperfusion fails to restore cardioprotection in prediabetic Zucker obese rats in vivo. Nutr. Metab. Cardiovasc. Dis. 20(10), 706-712 (2010).
    • (2010) Nutr. Metab. Cardiovasc. Dis. , vol.20 , Issue.10 , pp. 706-712
    • Huhn, R.1    Heinen, A.2    Hollmann, M.W.3
  • 68
    • 84881450484 scopus 로고    scopus 로고
    • Cyclosporine A at reperfusion fails to reduce infarct size in the in vivo rat heart
    • De PD, Chiari P, Teixeira G et al. Cyclosporine A at reperfusion fails to reduce infarct size in the in vivo rat heart. Basic Res. Cardiol. 108(5), 379 (2013).
    • (2013) Basic Res. Cardiol. , vol.108 , Issue.5 , pp. 379
    • De Pd Chiari, P.1    Teixeira, G.2
  • 69
    • 0141674628 scopus 로고    scopus 로고
    • Protection of myocardium by cyclosporin A and insulin: In vitro simulated ischemia study in human myocardium
    • Schneider A, Ad N, Izhar U et al. Protection of myocardium by cyclosporin A and insulin: in vitro simulated ischemia study in human myocardium. Ann. Thorac. Surg. 76(4), 1240-1245 (2003).
    • (2003) Ann. Thorac. Surg. , vol.76 , Issue.4 , pp. 1240-1245
    • Schneider, A.1    Ad, N.2    Izhar, U.3
  • 70
    • 21644475173 scopus 로고    scopus 로고
    • Mitochondrial permeability transition pore as a target for cardioprotection in the human heart
    • Shanmuganathan S, Hausenloy DJ, Duchen MR et al. Mitochondrial permeability transition pore as a target for cardioprotection in the human heart. Am. J. Physiol. Heart Circ. Physiol. 289(1), H237-H242 (2005).
    • (2005) Am. J. Physiol. Heart Circ. Physiol. , vol.289 , Issue.1
    • Shanmuganathan, S.1    Hausenloy, D.J.2    Duchen, M.R.3
  • 71
    • 48249109117 scopus 로고    scopus 로고
    • Effect of cyclosporine on reperfusion injury in acute myocardial infarction
    • Piot C, Croisille P, Staat P et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N. Engl. J. Med. 359(5), 473-481 (2008).
    • (2008) N. Engl. J. Med. , vol.359 , Issue.5 , pp. 473-481
    • Piot, C.1    Croisille, P.2    Staat, P.3
  • 72
    • 77949309749 scopus 로고    scopus 로고
    • Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction
    • Mewton N, Croisille P, Gahide G et al. Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction. J. Am. Coll. Cardiol. 55(12), 1200-1205 (2010).
    • (2010) J. Am. Coll. Cardiol. , vol.55 , Issue.12 , pp. 1200-1205
    • Mewton, N.1    Croisille, P.2    Gahide, G.3
  • 73
    • 84896546269 scopus 로고    scopus 로고
    • The effect of cyclosporin-A on peri-operative myocardial injury in adult patients undergoing coronary artery bypass graft surgery: A randomised controlled clinical trial
    • Hausenloy DJ, Kunst G, Boston-Griffiths E et al. The effect of cyclosporin-A on peri-operative myocardial injury in adult patients undergoing coronary artery bypass graft surgery: a randomised controlled clinical trial. Heart 100(7), 544-549 (2013).
    • (2013) Heart , vol.100 , Issue.7 , pp. 544-549
    • Hausenloy, D.J.1    Kunst, G.2    Boston-Griffiths, E.3
  • 74
    • 4444382387 scopus 로고    scopus 로고
    • Calcium-calcineurin signaling in the regulation of cardiac hypertrophy
    • Wilkins BJ, Molkentin JD. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. Biochem. Biophys. Res. Commun. 322(4), 1178-1191 (2004).
    • (2004) Biochem. Biophys. Res. Commun. , vol.322 , Issue.4 , pp. 1178-1191
    • Wilkins, B.J.1    Molkentin, J.D.2
  • 75
    • 0033921549 scopus 로고    scopus 로고
    • Cyclosporin A inhibits cardiac hypertrophy and enhances cardiac dysfunction during postinfarction failure in rats
    • Oie E, Bjornerheim R, Clausen OP et al. Cyclosporin A inhibits cardiac hypertrophy and enhances cardiac dysfunction during postinfarction failure in rats. Am. J. Physiol. Heart Circ. Physiol. 278(6), H2115-H2123 (2000).
    • (2000) Am. J. Physiol. Heart Circ. Physiol. , vol.278 , Issue.6
    • Oie, E.1    Bjornerheim, R.2    Clausen, O.P.3
  • 76
    • 0036895666 scopus 로고    scopus 로고
    • Effects of the calcineurin dependent signaling pathway inhibition by cyclosporin A on early and late cardiac remodeling following myocardial infarction
    • Youn TJ, Piao H, Kwon JS et al. Effects of the calcineurin dependent signaling pathway inhibition by cyclosporin A on early and late cardiac remodeling following myocardial infarction. Eur. J. Heart Fail. 4(6), 713-718 (2002).
    • (2002) Eur. J. Heart Fail. , vol.4 , Issue.6 , pp. 713-718
    • Youn, T.J.1    Piao, H.2    Kwon, J.S.3
  • 77
    • 77957842939 scopus 로고    scopus 로고
    • Cyclophilin D controls mitochondrial pore-dependent Ca(2+) exchange, metabolic flexibility, and propensity for heart failure in mice
    • Elrod JW, Wong R, Mishra S et al. Cyclophilin D controls mitochondrial pore-dependent Ca(2+) exchange, metabolic flexibility, and propensity for heart failure in mice. J. Clin. Invest. 120(10), 3680-3687 (2010).
    • (2010) J. Clin. Invest. , vol.120 , Issue.10 , pp. 3680-3687
    • Elrod, J.W.1    Wong, R.2    Mishra, S.3
  • 78
    • 80054883388 scopus 로고    scopus 로고
    • Mitochondrial cyclophilin-D as a potential therapeutic target for post-myocardial infarction heart failure
    • Lim SY, Hausenloy DJ, Arjun S et al. Mitochondrial cyclophilin-D as a potential therapeutic target for post-myocardial infarction heart failure. J. Cell. Mol. Med. 15(11), 2443-2451 (2011).
    • (2011) J. Cell. Mol. Med. , vol.15 , Issue.11 , pp. 2443-2451
    • Lim, S.Y.1    Hausenloy, D.J.2    Arjun, S.3
  • 79
    • 10244236553 scopus 로고    scopus 로고
    • The nonimmunosuppressive cyclosporin analogs NIM811 and UNIL025 display nanomolar potencies on permeability transition in brain-derived mitochondria
    • Hansson MJ, Mattiasson G, Mansson R et al. The nonimmunosuppressive cyclosporin analogs NIM811 and UNIL025 display nanomolar potencies on permeability transition in brain-derived mitochondria. J. Bioenerg. Biomembr. 36(4), 407-413 (2004).
    • (2004) J. Bioenerg. Biomembr. , vol.36 , Issue.4 , pp. 407-413
    • Hansson, M.J.1    Mattiasson, G.2    Mansson, R.3
  • 80
    • 66149129922 scopus 로고    scopus 로고
    • The cyclophilin inhibitor Debio 025 combined with PEG IFNalph2 significantly reduces viral load in treatment-naive hepatitis C patients
    • Flisiak R, Feinman SV, Jablkowski M et al. The cyclophilin inhibitor Debio 025 combined with PEG IFNalph2 significantly reduces viral load in treatment-naive hepatitis C patients. Hepatology 49(5), 1460-1468 (2009).
    • (2009) Hepatology , vol.49 , Issue.5 , pp. 1460-1468
    • Flisiak, R.1    Feinman, S.V.2    Jablkowski, M.3
  • 81
    • 77952368170 scopus 로고    scopus 로고
    • TRO40303, a new cardioprotective compound, inhibits mitochondrial permeability transition
    • Schaller S, Paradis S, Ngoh GA et al. TRO40303, a new cardioprotective compound, inhibits mitochondrial permeability transition. J. Pharmacol. Exp. Ther. 333(3), 696-706 (2010).
    • (2010) J. Pharmacol. Exp. Ther. , vol.333 , Issue.3 , pp. 696-706
    • Schaller, S.1    Paradis, S.2    Ngoh, G.A.3
  • 82
    • 84872077959 scopus 로고    scopus 로고
    • Rationale and design of the MITOCARE Study: A Phase II, multicenter, randomized, double-blind, placebo-controlled study to assess the safety and efficacy of TRO40303 for the reduction of reperfusion injury in patients undergoing percutaneous coronary intervention for acute myocardial infarction
    • Atar D, Abitbol JL, Arheden H et al. Rationale and design of the MITOCARE Study: a Phase II, multicenter, randomized, double-blind, placebo-controlled study to assess the safety and efficacy of TRO40303 for the reduction of reperfusion injury in patients undergoing percutaneous coronary intervention for acute myocardial infarction. Cardiology 123(4), 201-207 (2012).
    • (2012) Cardiology , vol.123 , Issue.4 , pp. 201-207
    • Atar, D.1    Abitbol, J.L.2    Arheden, H.3
  • 83
    • 84856134386 scopus 로고    scopus 로고
    • Targeting myocardial substrate metabolism in heart failure: Potential for new therapies
    • Ardehali H, Sabbah HN, Burke MA et al. Targeting myocardial substrate metabolism in heart failure: potential for new therapies. Eur. J. Heart Fail. 14(2), 120-129 (2012).
    • (2012) Eur. J. Heart Fail. , vol.14 , Issue.2 , pp. 120-129
    • Ardehali, H.1    Sabbah, H.N.2    Burke, M.A.3
  • 84
    • 84873413349 scopus 로고    scopus 로고
    • Mitochondria as a therapeutic target in heart failure
    • Bayeva M, Gheorghiade M, Ardehali H. Mitochondria as a therapeutic target in heart failure. J. Am. Coll. Cardiol. 61(6), 599-610 (2013).
    • (2013) J. Am. Coll. Cardiol. , vol.61 , Issue.6 , pp. 599-610
    • Bayeva, M.1    Gheorghiade, M.2    Ardehali, H.3
  • 85
    • 76849087987 scopus 로고    scopus 로고
    • Myocardial remodeling after infarction: The role of myofibroblasts
    • van den Borne SW, Diez J, Blankesteijn WM et al. Myocardial remodeling after infarction: the role of myofibroblasts. Nat. Rev. Cardiol. 7(1), 30-37 (2010).
    • (2010) Nat. Rev. Cardiol. , vol.7 , Issue.1 , pp. 30-37
    • Van Den Borne, S.W.1    Diez, J.2    Blankesteijn, W.M.3
  • 86
    • 84883592437 scopus 로고    scopus 로고
    • Mechanisms of altered Ca(2)(+) handling in heart failure
    • Luo M, Anderson ME. Mechanisms of altered Ca(2)(+) handling in heart failure. Circ. Res. 113(6), 690-708 (2013).
    • (2013) Circ. Res. , vol.113 , Issue.6 , pp. 690-708
    • Luo, M.1    Anderson, M.E.2
  • 87
    • 84880748603 scopus 로고    scopus 로고
    • Pathological ventricular remodeling: Mechanisms: Part of 2
    • Burchfield JS, Xie M, Hill JA. Pathological ventricular remodeling: mechanisms: part of 2. Circulation 128(4), 388-400 (2013).
    • (2013) Circulation , vol.128 , Issue.4 , pp. 388-400
    • Burchfield, J.S.1    Xie, M.2    Hill, J.A.3
  • 88
    • 84867738060 scopus 로고    scopus 로고
    • Mitochondria as a drug target in ischemic heart disease and cardiomyopathy
    • Brookes PS.
    • Walters AM, Porter GA Jr, Brookes PS. Mitochondria as a drug target in ischemic heart disease and cardiomyopathy. Circ. Res. 111(9), 1222-1236 (2012).
    • (2012) Circ. Res. , vol.111 , Issue.9 , pp. 1222-1236
    • Walters, A.M.1    Porter Jr., G.A.2
  • 89
    • 84864039693 scopus 로고    scopus 로고
    • Antioxidants and other pharmacological treatments for Friedreich ataxia
    • Kearney M, Orrell RW, Fahey M et al. Antioxidants and other pharmacological treatments for Friedreich ataxia. Cochrane Database Syst. Rev. 4, CD007791 (2012).
    • (2012) Cochrane Database Syst. Rev. , vol.4
    • Kearney, M.1    Orrell, R.W.2    Fahey, M.3
  • 90
    • 79957764437 scopus 로고    scopus 로고
    • Mitochondria-targeted antioxidants as therapies
    • Smith RA, Murphy MP. Mitochondria-targeted antioxidants as therapies. Discov. Med. 11(57), 106-114 (2011).
    • (2011) Discov. Med. , vol.11 , Issue.57 , pp. 106-114
    • Smith, R.A.1    Murphy, M.P.2
  • 91
    • 72449161760 scopus 로고    scopus 로고
    • Mitochondrial targeting of cyclosporin A enables selective inhibition of cyclophilin-D and enhanced cytoprotection after glucose and oxygen deprivation
    • Malouitre S, Dube H, Selwood D et al. Mitochondrial targeting of cyclosporin A enables selective inhibition of cyclophilin-D and enhanced cytoprotection after glucose and oxygen deprivation. Biochem. J. 425, 137-148 (2010).
    • (2010) Biochem. J. , vol.425 , pp. 137-148
    • Malouitre, S.1    Dube, H.2    Selwood, D.3
  • 92
    • 84855958407 scopus 로고    scopus 로고
    • A mitochondrial-targeted cyclosporin A with high binding affinity for cyclophilin D yields improved cytoprotection of cardiomyocytes
    • Dube H, Selwood D, Malouitre S et al. A mitochondrial-targeted cyclosporin A with high binding affinity for cyclophilin D yields improved cytoprotection of cardiomyocytes. Biochem. J. 441(3), 901-907 (2012).
    • (2012) Biochem. J. , vol.441 , Issue.3 , pp. 901-907
    • Dube, H.1    Selwood, D.2    Malouitre, S.3
  • 93
    • 77955283395 scopus 로고    scopus 로고
    • Animal and human studies with the mitochondria-targeted antioxidant MitoQ
    • Smith RA, Murphy MP. Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Ann. NY Acad. Sci. 1201, 96-103 (2010).
    • (2010) Ann. NY Acad. Sci. , vol.1201 , pp. 96-103
    • Smith, R.A.1    Murphy, M.P.2
  • 94
    • 77955792985 scopus 로고    scopus 로고
    • A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinsons disease
    • Snow BJ, Rolfe FL, Lockhart MM et al. A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinsons disease. Mov. Disord. 25(11), 1670-1674 (2010).
    • (2010) Mov. Disord. , vol.25 , Issue.11 , pp. 1670-1674
    • Snow, B.J.1    Rolfe, F.L.2    Lockhart, M.M.3
  • 95
    • 77956496245 scopus 로고    scopus 로고
    • The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a Phase II study of hepatitis C patients
    • Gane EJ, Weilert F, Orr DW et al. The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a Phase II study of hepatitis C patients. Liver Int. 30(7), 1019-1026 (2010).
    • (2010) Liver Int. , vol.30 , Issue.7 , pp. 1019-1026
    • Gane, E.J.1    Weilert, F.2    Orr, D.W.3
  • 96
    • 84860481279 scopus 로고    scopus 로고
    • Regulation of mitochondrial processes by protein S-nitrosylation
    • Piantadosi CA. Regulation of mitochondrial processes by protein S-nitrosylation. Biochim. Biophys. Acta 1820(6), 712-721 (2012).
    • (2012) Biochim. Biophys. Acta , vol.1820 , Issue.6 , pp. 712-721
    • Piantadosi, C.A.1
  • 97
    • 67649757115 scopus 로고    scopus 로고
    • A mitochondria-targeted S-nitrosothiol modulates respiration, nitrosates thiols, and protects against ischemia-reperfusion injury
    • Prime TA, Blaikie FH, Evans C et al. A mitochondria-targeted S-nitrosothiol modulates respiration, nitrosates thiols, and protects against ischemia-reperfusion injury. Proc. Natl Acad. Sci. USA 106(26), 10764-10769 (2009).
    • (2009) Proc. Natl Acad. Sci. USA , vol.106 , Issue.26 , pp. 10764-10769
    • Prime, T.A.1    Blaikie, F.H.2    Evans, C.3
  • 98
    • 84880253528 scopus 로고    scopus 로고
    • Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex i
    • Chouchani ET, Methner C, Nadtochiy SM et al. Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I. Nat. Med. 19(6), 753-759 (2013).
    • (2013) Nat. Med. , vol.19 , Issue.6 , pp. 753-759
    • Chouchani, E.T.1    Methner, C.2    Nadtochiy, S.M.3
  • 99
    • 4544370680 scopus 로고    scopus 로고
    • Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury
    • Zhao K, Zhao GM, Wu D et al. Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J. Biol. Chem. 279(33), 34682-34690 (2004).
    • (2004) J. Biol. Chem. , vol.279 , Issue.33 , pp. 34682-34690
    • Zhao, K.1    Zhao, G.M.2    Wu, D.3
  • 100
    • 84881090284 scopus 로고    scopus 로고
    • The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin
    • Birk AV, Liu S, Soong Y et al. The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. J. Am. Soc. Nephrol. 24(8), 1250-1261 (2013).
    • (2013) J. Am. Soc. Nephrol. , vol.24 , Issue.8 , pp. 1250-1261
    • Birk, A.V.1    Liu, S.2    Soong, Y.3
  • 101
    • 34247209532 scopus 로고    scopus 로고
    • Potent mitochondria-targeted peptides reduce myocardial infarction in rats
    • Cho J, Won K, Wu D et al. Potent mitochondria-targeted peptides reduce myocardial infarction in rats. Coron. Artery Dis. 18(3), 215-220 (2007).
    • (2007) Coron. Artery Dis. , vol.18 , Issue.3 , pp. 215-220
    • Cho, J.1    Won, K.2    Wu, D.3
  • 102
    • 84875149020 scopus 로고    scopus 로고
    • Reduction of ischemia/reperfusion injury with bendavia, a mitochondria-targeting cytoprotective peptide
    • Kloner RA, Hale SL, Dai W et al. Reduction of ischemia/reperfusion injury with bendavia, a mitochondria-targeting cytoprotective peptide. J. Am. Heart Assoc. 1(3), e001644 (2012).
    • (2012) J. Am. Heart Assoc. , vol.1 , Issue.3
    • Kloner, R.A.1    Hale, S.L.2    Dai, W.3
  • 103
    • 79959525058 scopus 로고    scopus 로고
    • Mitochondrial targeted antioxidant peptide ameliorates hypertensive cardiomyopathy
    • Dai DF, Chen T, Szeto H et al. Mitochondrial targeted antioxidant peptide ameliorates hypertensive cardiomyopathy. J. Am. Coll. Cardiol. 58(1), 73-82 (2011).
    • (2011) J. Am. Coll. Cardiol. , vol.58 , Issue.1 , pp. 73-82
    • Dai, D.F.1    Chen, T.2    Szeto, H.3
  • 104
    • 79954694973 scopus 로고    scopus 로고
    • Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure
    • Dai DF, Johnson SC, Villarin JJ et al. Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure. Circ. Res. 108(7), 837-846 (2011).
    • (2011) Circ. Res. , vol.108 , Issue.7 , pp. 837-846
    • Dai, D.F.1    Johnson, S.C.2    Villarin, J.J.3
  • 105
    • 84875422028 scopus 로고    scopus 로고
    • Rationale and design of the EMBRACE STEMI study: A Phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction
    • Chakrabarti AK, Feeney K, Abueg C et al. Rationale and design of the EMBRACE STEMI study: a Phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction. Am. Heart J. 165(4), 509-514 (2013).
    • (2013) Am. Heart J. , vol.165 , Issue.4 , pp. 509-514
    • Chakrabarti, A.K.1    Feeney, K.2    Abueg, C.3
  • 107
    • 79958172986 scopus 로고    scopus 로고
    • Preconditioning involves selective mitophagy mediated by Parkin and p62/SQSTM1
    • Huang C, Andres AM, Ratliff EP et al. Preconditioning involves selective mitophagy mediated by Parkin and p62/SQSTM1. PLoS ONE 6(6), e20975 (2011).
    • (2011) PLoS ONE , vol.6 , Issue.6
    • Huang, C.1    Andres, A.M.2    Ratliff, E.P.3
  • 108
    • 84913546616 scopus 로고    scopus 로고
    • Mitophagy is required for acute cardioprotection by simvastatin
    • doi:10.1089/ars.2013.5416 Epub ahead of print
    • Andres AM, Hernandez G, Lee P et al. Mitophagy is required for acute cardioprotection by simvastatin. Antioxid. Redox Signal. doi:10.1089/ars.2013. 5416 (2013) (Epub ahead of print).
    • (2013) Antioxid. Redox Signal.
    • Andres, A.M.1    Hernandez, G.2    Lee, P.3
  • 109
    • 84155180848 scopus 로고    scopus 로고
    • P53-TIGAR axis attenuates mitophagy to exacerbate cardiac damage after ischemia
    • Hoshino A, Matoba S, Iwai-Kanai E et al. p53-TIGAR axis attenuates mitophagy to exacerbate cardiac damage after ischemia. J. Mol. Cell. Cardiol. 52(1), 175-184 (2012).
    • (2012) J. Mol. Cell. Cardiol. , vol.52 , Issue.1 , pp. 175-184
    • Hoshino, A.1    Matoba, S.2    Iwai-Kanai, E.3
  • 110
    • 84872283780 scopus 로고    scopus 로고
    • Parkin protein deficiency exacerbates cardiac injury and reduces survival following myocardial infarction
    • Kubli DA, Zhang X, Lee Y et al. Parkin protein deficiency exacerbates cardiac injury and reduces survival following myocardial infarction. J. Biol. Chem. 288(2), 915-926 (2013).
    • (2013) J. Biol. Chem. , vol.288 , Issue.2 , pp. 915-926
    • Kubli, D.A.1    Zhang, X.2    Lee, Y.3
  • 111
    • 84876889535 scopus 로고    scopus 로고
    • Loss of PINK1 increases the hearts vulnerability to ischemia-reperfusion injury
    • Siddall HK, Yellon DM, Ong SB et al. Loss of PINK1 increases the hearts vulnerability to ischemia-reperfusion injury. PLoS ONE 8(4), e62400 (2013).
    • (2013) PLoS ONE , vol.8 , Issue.4
    • Siddall, H.K.1    Yellon, D.M.2    Ong, S.B.3
  • 112
    • 84880673845 scopus 로고    scopus 로고
    • Pharmacological approaches to restore mitochondrial function
    • Andreux PA, Houtkooper RH, Auwerx J. Pharmacological approaches to restore mitochondrial function. Nat. Rev. Drug Discov. 12(6), 465-483 (2013).
    • (2013) Nat. Rev. Drug Discov. , vol.12 , Issue.6 , pp. 465-483
    • Andreux, P.A.1    Houtkooper, R.H.2    Auwerx, J.3
  • 113
    • 84883795966 scopus 로고    scopus 로고
    • Mitochondrial dynamics in the adult cardiomyocytes: Which roles for a highly specialized cell Front
    • Piquereau J, Caffin F, Novotova M et al. Mitochondrial dynamics in the adult cardiomyocytes: which roles for a highly specialized cell Front. Physiol. 4, 102 (2013).
    • (2013) Physiol. , vol.4 , Issue.102
    • Piquereau, J.1    Caffin, F.2    Novotova, M.3
  • 114
    • 84879858842 scopus 로고    scopus 로고
    • Mitochondrial dynamics in cardiovascular health and disease
    • Ong SB, Hall AR, Hausenloy DJ. Mitochondrial dynamics in cardiovascular health and disease. Antioxid. Redox Signal. 19(4), 400-414 (2013).
    • (2013) Antioxid. Redox Signal. , vol.19 , Issue.4 , pp. 400-414
    • Ong, S.B.1    Hall, A.R.2    Hausenloy, D.J.3
  • 115
    • 77952236126 scopus 로고    scopus 로고
    • Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury
    • Ong SB, Subrayan S, Lim SY et al. Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation 121(18), 2012-2022 (2010).
    • (2010) Circulation , vol.121 , Issue.18 , pp. 2012-2022
    • Ong, S.B.1    Subrayan, S.2    Lim, S.Y.3
  • 116
    • 84255192658 scopus 로고    scopus 로고
    • Cardiomyocyte deletion of mitofusin-1 leads to mitochondrial fragmentation and improves tolerance to ROS-induced mitochondrial dysfunction and cell death
    • Papanicolaou KN, Ngoh GA, Dabkowski ER et al. Cardiomyocyte deletion of mitofusin-1 leads to mitochondrial fragmentation and improves tolerance to ROS-induced mitochondrial dysfunction and cell death. Am. J. Physiol. Heart Circ. Physiol. 302(1), H167-H179 (2012).
    • (2012) Am. J. Physiol. Heart Circ. Physiol. , vol.302 , Issue.1
    • Papanicolaou, K.N.1    Ngoh, G.A.2    Dabkowski, E.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.